Trial Profile
A randomised trial of effective and cost effectiveness of supervised versus unsupervised administration of buprenorphine-naloxone for heroin dependence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Heroin-related disorders
- Focus Therapeutic Use
- 01 Sep 2011 New trial record